Ms. Armellino has been involved in various stages of patent litigation, including discovery, motion practice, and pretrial proceedings. Some of her engagements include:
- Representing Dr. Reddy’s Laboratories in litigation concerning its generic equivalent to Suboxone®, a product used to treat opioid use disorder.
- Representing Teva in Hatch-Waxman litigation related to a generic version of a drug product for the treatment of ADHD.
- Represented Civiq Smartscapes, LLC against claims of patent infringement relating to digital outdoor displays.
- Represented Actavis Laboratories in Hatch-Waxman litigation concerning its generic equivalent to Minivelle®, an estradiol transdermal system.
Ms. Armellino maintains an active pro bono practice, including working with the ACLU of Massachusetts and ACLU of Michigan to challenge policies and practices denying medication for the treatment of opioid use disorder (MOUD) to incarcerated people.